Clinical Trial Update: Hyperemesis Gravidarum Risk Reduction With Metformin [Phase 2]

View source ↗

Summary

A Phase 2 trial is evaluating whether metformin can reduce the risk of hyperemesis gravidarum. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperemesis Gravidarum

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: University of Southern California | Conditions: Hyperemesis Gravidarum | Phase 2 | Status: NOT_YET_RECRUITING